Macrophage-targeted oligonucleotide therapeutics to downregulate inflammatory cytokines in non-alcoholic steatohepatitis
Non-alcoholic fatty liver disease (NAFLD) is thought the be the most common chronic liver disease in the world, affecting roughly a quarter of the global population. NAFLD describes a continuum of liver disease which is defined by the presence of liver steatosis, inflammation...
| Published: |
|
|---|---|
| Online Access: | http://hdl.handle.net/2047/D20416550 |